Alaa E. Elkharwily, M.D. v. Mayo Holding Company ( 2016 )


Menu:
  •                  United States Court of Appeals
    For the Eighth Circuit
    ___________________________
    No. 15-1492
    ___________________________
    Alaa E. Elkharwily, M.D.
    lllllllllllllllllllll Plaintiff - Appellant
    v.
    Mayo Holding Company; Mayo Clinic Health System-Albert Lea; Mayo
    Foundation; Mark Ciota, M.D.; John Grzybowski, M.D.; Dieter Heinz, M.D.;
    Robert E. Nesse, M.D.; Steve Underdahl; Stephen Waldhoff
    lllllllllllllllllllll Defendants - Appellees
    ____________
    Appeal from United States District Court
    for the District of Minnesota - Minneapolis
    ____________
    Submitted: November 19, 2015
    Filed: May 20, 2016
    [Published]
    ____________
    Before SMITH, BYE, and BENTON, Circuit Judges.1
    ____________
    PER CURIAM.
    1
    This opinion is being filed by Judge Smith and Judge Benton pursuant to 8th
    Cir. Rule 47E.
    Alaa E. Elkharwily, M.D., sued Mayo Holding Company, Mayo Clinic Health
    System-Albert Lea (the Clinic), Mayo Foundation, and Mayo staff2 (collectively
    Mayo) for wrongful employment termination and retaliation. The district court3
    granted Mayo's motion to dismiss in part and its later motion for summary judgment,
    while denying Dr. Elkharwily's motion for reconsideration and motion for additional
    time for discovery. Dr. Elkharwily appeals. We affirm.
    I
    Dr. Elkharwily, a medical doctor certified in internal medicine, worked as a
    hospitalist at the Clinic from September 7, 2010, to December 10, 2010. As a
    hospitalist, his job duties included providing care for admitted patients and refining
    the "hand-off" process for patients released to the care of their primary providers after
    hospitalization ended. Dr. Elkharwily reported directly to Dr. Dieter Heinz, Chair of
    the Division of Medicine, and indirectly to an administrative team including Dr. Mark
    Ciota, Dr. John Grzybowski, Steve Underdahl (Hospital Administrator), and Lori
    Routh (Nurse Executive).
    Under Clinic policy, new employees–including Dr. Elkharwily–are on
    probationary status for 90-days and evaluated in writing before the 90th day. At the
    end of this period, the evaluators recommend either continued employment, extension
    of probation, or termination. Dr. Elkharwily also participated in Minnesota's Health
    Professionals Service Program (HPSP) while employed at the Albert Lea Clinic
    because he suffers from bipolar disorder. This program required a work-site monitor
    2
    The named Mayo medical staff are Mark Ciota, M.D.; John Grzybowski,
    M.D.; Dieter Heinz, M.D.; Robert E. Nesse, M.D.; Steve Underdahl; and Stephen
    Waldhoff.
    3
    The Honorable David S. Doty, United States District Judge for the District of
    Minnesota.
    -2-
    to supervise Dr. Elkharwily and submit quarterly reports assessing his job
    performance. His work-site monitor at the Clinic was Dr. Ciota.
    The Hospital Administrator evaluated Dr. Elkharwily's job performance for his
    90-day review. The Administrator solicited information from hospital administration,
    nursing staff, physician leadership, and physician colleagues about Dr. Elkharwily's
    job performance, detailing the staff's concerns in a November evaluation: difficulty
    organizing and prioritizing his work; unreachable to staff; adversarial, resistant to
    admitting patients, and unnecessarily generated work for the emergency departments;
    untrusted by the nursing staff for his instructions or interpretation of events;
    incorrectly informing nursing staff that his contract limits the number of patients he
    is required to care for to twelve; and difficulty timely completing documentation.
    Despite these concerns, the Hospital Administrator and Dr. Elkharwily's direct
    supervisor extended Dr. Elkharwily's employment probationary period by 90 days.
    As part of the evaluation, the Hospital Administrator and direct supervisor planned
    to discuss the evaluation with Dr. Elkharwily shortly after its completion.
    Simultaneously, Dr. Ciota prepared Dr. Elkharwily's confidential HPSP report.
    Dr. Ciota interviewed five nursing supervisors about his job performance. Although
    the Hospital Administrator did not interview these supervisors, their answers reflected
    many of the same concerns as the evaluation. Dr. Elkharwily did not answer calls and
    was difficult to locate, had very poor organizational skills, did not see patients in a
    timely manner, frequently challenged patients' end-of-life choices, became easily
    frustrated, did not always provide an accurate interpretation of events, and became
    difficult to work with when feeling overworked. Dr. Ciota sent the HPSP report
    Minnesota on December 6, 2010.
    Before the Hospital Administrator and direct supervisor could discuss the
    evaluation results with Dr. Elkharwily, the following events took place. On
    December 7, Dr. Elkharwily gave an order to a nurse to give a patient intravenous
    -3-
    (IV) Tylenol. The nurse questioned Dr. Elkharwily because she had never heard of
    IV Tylenol. Dr. Elkharwily insisted he had given IV Tylenol to a patient two days
    earlier. The nurse contacted the hospital pharmacist, who verified the formulary did
    not carry IV Tylenol.
    The next day, a nursing supervisor reported the incident to the Nurse
    Executive, Lori Routh. She and the Hospital Administrator discussed the events with
    Dr. Elkharwily. Dr. Elkharwily reiterated that he believed IV Tylenol was available
    at the Albert Lea Clinic formulary because he had administered it to a patient a few
    days earlier. The Administrator explained that IV Tylenol was not available in the
    formulary. Dr. Elkharwily immediately changed his story stating, "It would have
    been the right medication to use had it been available."
    In light of the inconsistent responses, the Hospital Administrator and Nurse
    Executive were concerned about patient safety and Dr. Elkharwily's overall
    trustworthiness. The Clinic placed Dr. Elkharwily on paid administrative leave
    pending further investigation. The Hospital Administrator and Nurse Executive
    interviewed nursing staff to assess Dr. Elkharwily's patient safety. The interviews
    matched the concerns in his 90-day evaluation and HPSP report, including that he
    was disorganized, dishonest, difficult to reach while on duty, and difficult with
    patients.
    On December 10, the Hospital Administrator outlined his concerns about Dr.
    Elkharwily's job performance to Dr. Grzybowski. The Administrator concluded,
    "Based on the volume and magnitude of concerns about Dr. Elkhawily and his
    performance as a hospitalist, it appears that a majority of team members have lost
    confidence in his ability and are very pessimistic about his ability to improve."
    Later that day, after consulting with in-house counsel, the Clinic's
    administrative team recommended Dr. Ciota end Dr. Elkharwily's employment or
    -4-
    permit him to resign in lieu of termination. Dr. Ciota agreed. Members of the
    administrative team and the Director of Human Resources and Staff Development,
    informed Dr. Elkharwily of the decision to end his employment. Disagreeing with
    the decision, he said he would consider resigning. On December 11, Dr. Elkharwily
    resigned.
    Three days later, Dr. Elkharwily sent multiple emails to Dr. Ciota challenging
    the basis for his termination and filed an administrative appeal. Mayo denied the
    appeal on July 8, 2011. Dr. Elkharwily filed suit, alleging defamation and violations
    of the Minnesota Vulnerable Adults Act (MVAA), the Emergency Medical Treatment
    and Active Labor Act (EMTALA), the Minnesota Whistleblower Act, and the False
    Claims Act.
    The MVAA claim derives from his allegation that on December 7, the Clinic
    provided substandard care to two patients, endangering their lives. Dr. Elkharwily
    claims he reported the incidents to Dr. Ciota on December 11 and 13.
    The EMTALA claims were based on two events between December 7 and 8,
    2010. First, Dr. Elkharwily submits Dr. Grzybowski, who was on call, refused to
    come in and treat two patients within a reasonable period of time. Second, Dr.
    Elkharwily refused to transfer an unstabilized patient and argues Mayo terminated his
    employment in retaliation for his refusal to transfer the patient. Dr. Elkhawily asserts
    he reported these violations to his supervisors.
    The Minnesota Whistleblower Act claim derives from an incident on
    September 15, 2010, when he thought a treating physician had engaged in "criminal
    negligence" by failing to admit a patient whom Dr. Elkhawily believed to be having
    a heart attack.
    The False Claims Act claim stems from an email he sent to his supervisors in
    November, suggesting the Clinic establish an inpatient wound-care team because not
    -5-
    having one was "a huge loss of revenue for the hospital." Dr. Elkharwily argues that
    this email reported Mayo was providing unlicensed care and unlawfully billing
    patients, constituting a complaint of a violation of the False Claims Act.
    The defamation claim alleged Mayo made false statements about his job
    performance during his initial termination meeting and review meeting. Dr.
    Elkharwily asserts Mayo's statements were incorrect, unsubstantiated, and detrimental
    to his reputation in the medical community.
    Mayo moved to dismiss Dr. Elkharwily's claims. The district court dismissed
    Dr. Elkharwily's claims for defamation, violations of MVAA, and part of his
    EMTALA claim about terminating his employment for refusing to transfer a patient.
    On the remaining claims, Mayo moved for summary judgment. Opposing
    summary judgment, Dr. Elkharwily filed a timely but over-length response and
    attached a 51-page declaration, incorporated by reference. The district court struck
    Dr. Elkharwily's declaration because his submission was already over the acceptable
    word limit. The district court also denied Dr. Elkharwily's motion for additional
    discovery, the subject of multiple prior unsuccessful motions.
    The district court granted Mayo's motion for summary judgment, dismissing
    the remaining claims with prejudice. Dr. Elkharwily appeals.
    II
    A
    Dr. Elkharwily argues the district court erred in granting Mayo's motion to
    dismiss his claims under the MVAA, for defamation, and under EMTALA.
    -6-
    "We review de novo a district court's dismissal for failure to state a claim,
    taking all facts alleged in the complaint as true." Cuellar-Aguilar v. Deggeller
    Attractions, Inc., 
    812 F.3d 614
    , 618 (8th Cir. 2015), reh'g denied (Feb. 10, 2016). To
    avoid dismissal under Rule 12(b)(6), "a complaint must contain sufficient factual
    matter . . . 'to state a claim to relief that is plausible on its face.'" McCaffree Fin.
    Corp. v. Principal Life Ins. Co., 
    811 F.3d 998
    , 1002 (8th Cir. 2016), reh'g and reh'g
    en banc denied (Feb. 17, 2016) (quoting Braden v. Wal-Mart Stores, Inc., 
    588 F.3d 585
    , 594 (8th Cir. 2009)). "A claim is plausible on its face 'when the plaintiff pleads
    factual content that allows the court to draw the reasonable inference that the
    defendant is liable for the misconduct alleged." 
    Id. (quoting Ashcroft
    v. Iqbal, 
    556 U.S. 662
    , 678 (2009)).
    Under the MVAA, if "[a] mandated reporter . . . has reason to believe that a
    vulnerable adult is being or has been maltreated . . . [he] shall immediately report the
    information . . . ." Minn. Stat. § 626.557, subdiv. 3(a). This requirement is satisfied
    either by an oral report to the facility's common entry point or by following the
    facility's internal reporting procedure. 
    Id. at subdiv.
    4, 4a.
    Dr. Elkharwily concedes he did not report the violations to a common entry
    point. And, his conclusory allegations do not show compliance with the internal
    reporting procedure. Dr. Elkharwily alleged he reported violations under MVAA to
    the Clinic staff, including Dr. Ciota, Dr. Grzybowski, his direct supervisor, and the
    Hospital Administrator. However, nowhere does he allege his reporting compliance
    with the internal reporting procedure. The district court properly dismissed his claim.
    B
    Dr. Elkharwily alleged Mayo made false statements about his performance
    during his initial termination meeting and review meeting, which amount to
    defamation. The district court dismissed because Mayo's statements were protected
    -7-
    by qualified privilege. Dr. Elkharwily argues Mayo did not have reasonable grounds
    for believing its false statements. We disagree.
    Under Minnesota law, a plaintiff must prove three elements to establish a
    defamation claim: "(1) the defamatory statement is communicated to someone other
    than the plaintiff, (2) the statement is false, and (3) the statement tends to harm the
    plaintiff's reputation and to lower the plaintiff in the estimation of the community."
    Bahr v. Boise Cascade Corp., 
    766 N.W.2d 910
    , 919-20 (Minn. 2009) (internal
    quotation marks omitted) (cited in Chambers v. Travelers Cos., Inc., 
    668 F.3d 559
    ,
    564 (8th Cir. 2012)). However, even if the plaintiff proves the three elements, the
    defendant may be entitled to qualified privilege if the statement was "made upon a
    proper occasion, from a proper motive, and . . . based upon reasonable or probable
    cause." Stuempges v. Parke, Davis & Co., 
    297 N.W.2d 252
    , 256-57 (Minn. 1980).
    "Communications between an employer's agents made in the course of investigating
    or punishing employee misconduct are made upon a proper occasion and for a proper
    purpose, as the employer has an important interest in protecting itself and the public
    against dishonest or otherwise harmful employees." McBride v. Sears, Roebuck &
    Co., 
    235 N.W.2d 371
    , 374 (Minn. 1975) (cited in Sherman v. Rinchem Co., 
    687 F.3d 996
    , 1008 (8th Cir. 2012)).
    Mayo's allegedly defamatory statements are protected by qualified privilege
    because they were made in the course of evaluating, investigating, or punishing Dr.
    Elkharwily's performance. Mayo's critiques of his performance were made upon
    proper occasion and from proper motive as part of two mandatory and independent
    evaluations–the HPSP report and 90-day review. Mayo's alleged defamatory
    statements were also based on reasonable cause, the confidential opinions of several
    colleagues. Likewise, Mayo's allegedly defamatory statements were made during the
    course of its investigation of the IV Tylenol incident. Mayo's motive and occasion
    for making the allegedly defamatory statements were proper and the criticisms were
    -8-
    based on reasonable cause. The district court properly dismissed Dr. Elkharwily's
    defamation claim.
    C
    Dr. Elkharwily alleged Mayo terminated his employment in retaliation for his
    refusal to authorize the transfer of an unstabilized patient, in violation of the
    EMTALA. The district court partially dismissed Dr. Elkharwily's claim because his
    January 3, 2011, written statement to the Minnesota Board of Medical Practice
    reporting Mayo's violations directly contradicted his EMTALA allegation in his
    complaint. Dr. Elkharwily contends that not only did his sworn statement constitute
    evidence outside of the pleadings, but also he had expert testimony by Dr. Daniel
    Doornink refuting his sworn statement and raising an issue of fact. Dr. Elkharwily
    believes that the district court should have converted the motion to dismiss into a
    motion for summary judgment.
    Because Dr. Elkharwily referenced his January 2011 report in his second
    amended complaint, the district court properly considered his testimony and
    appropriately decided this issue in the motion to dismiss. Assuming without deciding
    the district court erred in dismissing this portion of Dr. Elkhawily's claim under Rule
    12(b)(6), such an error is harmless because summary judgment was appropriate, as
    Dr. Doornink's declaration does not trump Elkharwily's written statement
    contradicting his allegation. Fed. R. Civ. P. 61; see Quinn v. St. Louis Cty., 
    653 F.3d 745
    , 750 (8th Cir. 2011) (finding error in dismissing claim under 12(b)(6) was
    harmless because summary judgment was appropriate on all claims); Gibb v. Scott,
    
    958 F.2d 814
    , 816-17 (8th Cir. 1992) (noting the district court's failure to convert
    12(b)(6) motion to summary judgment motion when considering matters outside
    pleadings may be harmless when record supports summary judgment). Dr.
    Elkharwily's signed and notarized statement stated the patient "had been stabilized"
    -9-
    before being transferred. An EMTALA claim does not apply to patients who are
    stabilized. 42 U.S.C. § 1395dd(b)(1).
    D
    Dr. Elkharwily initially argued Mayo terminated his employment as retaliation
    for reporting violations under the Minnesota Whistleblower Act, the EMTALA, and
    the False Claims Act. The district court granted summary judgment to Mayo on all
    three issues. The court determined Dr. Elkharwily failed to establish pretext for
    retaliation under the Minnesota Whistleblower Act and EMTALA, or that Mayo's
    decision to terminate his employment was motivated solely by his reports of False
    Claims Act violations. Dr. Elkharwily claims the district court's findings were
    erroneous because the record does not support its findings.
    "We review a district court's grant of summary judgment de novo, viewing the
    evidence in the light most favorable to the non-moving party and giving the non-
    moving party the benefit of all reasonable inferences." United States v. Dico, Inc.,
    
    808 F.3d 342
    , 346 (8th Cir. 2015). Summary judgment is proper only if the moving
    party satisfies its burden of demonstrating that no genuine issues of material fact
    remain for trial. Fed. R. Civ. P. 56(a).
    An employer shall not terminate an employee as retaliation for reporting a
    violation under the Minnesota Whistleblower Act, EMTALA, or False Claims Act.
    See Minn. Stat. § 181.932, subdiv. 1(1) (providing the Minnesota Whistleblowers
    Act protects an employee from retaliatory discharge if "the employee . . . in good
    faith, reports a violation, suspected violation, or planned violation of any federal or
    state law . . . to an employer"); 42 U.S.C. § 1395dd(I) ("A participating hospital may
    not penalize or take adverse action against a . . . physician because the . . . physician
    refuses to authorize the transfer of an individual with an emergency medical condition
    that has not been stabilized or against any hospital employee because the employee
    -10-
    reports a violation of a requirement of this section."); 31 U.S.C. § 3730(h) (stating the
    False Claims Act whistleblower statute protects employees "discharged . . . because
    of lawful acts done by the employee" in furtherance of a civil action to stop false
    claims). Dr. Elkharwily alleged Mayo engaged in activity that violated the Minnesota
    Whistleblower Act, EMTALA, and False Claims Act including: refusing to admit a
    patient whom Dr. Elkharwily believed to be having a heart attack, in violation of the
    Minnesota Whistleblower Act; an on-call doctor refusing to come in and treat a
    patient in violation of the EMTALA; and billing patients fraudulently for unlicensed
    care in violation of the False Claims Act. Dr. Elkharwily argues Mayo terminated his
    employment in retaliation for reporting these violations.
    In the absence of direct evidence of retaliation, courts apply the McDonnell
    Douglas burden-shifting framework to the Minnesota Whistleblower Act claims.
    McDonnell Douglas Corp. v. Green, 
    411 U.S. 792
    (1973); see Hilt v. St. Jude Med.
    S.C., Inc., 
    687 F.3d 375
    , 378 (8th Cir. 2012) (applying McDonnell Douglas analysis
    to a Minnesota Whistleblower Act claim). In their briefs, the parties agree the
    McDonnell Douglas burden-shifting analysis also applies to a retaliation claim under
    EMTALA. See Ritten v. Lapeer Reg'l Med. Ctr., 
    611 F. Supp. 2d 696
    , 716 (E.D.
    Mich. 2009) (applying McDonnell Douglas analysis to an EMTALA retaliation
    claim); Lopes v. Kapiloani Med. Ctr. for Women & Children, 
    410 F. Supp. 2d 939
    ,
    947 (D. Haw. 2005) (same). We assume, without deciding, the McDonnell Douglas
    analysis applies. 
    Ritten, 611 F. Supp. 2d at 716
    ("As the parties observe, there is no
    case law addressing the standards that should govern a claim under the EMTALA's
    anti-retaliation provision, so both sides have agreed that it is appropriate to analyze
    Plaintiff's claim under the standards that govern Title VII claims of retaliation.").
    "Under McDonnell Douglas, the initial burden is on the plaintiff to establish
    a prima facie case." Pedersen v. Bio-Med. Applications of Minn., 
    775 F.3d 1049
    ,
    1054 (8th Cir. 2015) (quoting Buytendorp v. Extendicare Health Servs., Inc., 
    498 F.3d 826
    , 834 (8th Cir. 2007)). To establish a prima facie case, a plaintiff must
    -11-
    prove: "(1) conduct by the employee that is protected by the Act, (2) an adverse
    employment action directed at the employee, and (3) a causal connection between the
    protected conduct and the adverse action." 
    Id. "If the
    plaintiff establishes a prima
    facie case, a burden shifts to the employer to articulate a legitimate reason for the
    adverse action." 
    Id. Once a
    legitimate reason is articulated, the burden then shifts
    back to "the plaintiff to prove that the proffered reason is merely a pretext and that
    retaliatory animus motivated the adverse action." 
    Id. Similarly, to
    establish retaliation under the False Claims Act, the "plaintiff
    must prove that (1) the plaintiff was engaged in conduct protected by the [False
    Claims Act]; (2) the plaintiff's employer knew that the plaintiff engaged in the
    protected activity; (3) the employer retaliated against the plaintiff; and (4) the
    retaliation was motivated solely by the plaintiff's protected activity." Schell v.
    Bluebird Media, LLC, 
    787 F.3d 1179
    , 1187 (8th Cir. 2015) (quoting Schuhardt v.
    Washington Univ., 
    390 F.3d 563
    , 566 (8th Cir. 2004)).
    Assuming without deciding Dr. Elkharwily established prima facie cases under
    the Minnesota Whistleblower Act and EMTALA or that he engaged in protected
    conduct under the False Claims Act, he failed to establish his employment
    termination was pretext for retaliation or motivated solely by his reports of Minnesota
    Whistleblower Act, EMTALA, or False Claims Act violations. Rather, Mayo
    articulated a legitimate, nondiscriminatory reason for terminating Dr. Elkharwily's
    employment; namely, his poor job performance. Although Dr. Elkharwily argues
    Mayo's performance evaluations and IV Tylenol investigation were shams to
    terminate his employment, this argument is not supported by the record. Dr.
    Elkharwily's performance evaluations were either required for all employees under
    the Albert Lea Clinic policy or specifically required for Dr. Elkharwily because of his
    participation in the HPSP. Further, the evaluations were confidential, based on
    feedback from numerous staff interviews, and performed independently of each other.
    Mayo's investigation into the IV Tylenol incident was also the proper protocol in
    -12-
    response to Dr. Elkharwily's inconsistent version of the events which raised
    legitimate patient-safety concerns.
    Mayo terminated Dr. Elkharwily's employment for poor job performance.
    Nothing in the record suggests pretext of retaliatory motive. Dr. Elkharwily failed to
    meet his burden of establishing pretext for retaliation under the Minnesota
    Whistleblower Act and EMTALA, or that Mayo's decision to terminate his
    employment was "solely motivated" by his reports of False Claims Act violations.
    We affirm the grant of summary judgment to Mayo.
    E
    Dr. Elkharwily argues the district court abused its discretion by denying his
    motion for reconsideration of the district court's order striking his 51-page
    declaration. Reviewing for abuse of discretion, we disagree. See Lowry ex rel. Crow
    v. Watson Chapel Sch. Dist., 
    540 F.3d 752
    , 763 (8th Cir. 2008).
    The district court did not abuse its discretion by striking Dr. Elkharwily's 51-
    page declaration that doubled the word limit under the local rules. See D. Minn. LR
    7.1(f)(1). "[T]he district court has considerable leeway in the application of its local
    rules." Silberstein v. I.R.S., 
    16 F.3d 858
    , 860 (8th Cir. 1994). The district court
    accepted Dr. Elkharwily's over-length response brief and acted within its discretion
    to deny the 51-page declaration he tried to incorporate by reference. The district
    court also did not abuse its discretion in denying the motion to reconsider.
    F
    Dr. Elkharwily argues the district court abused its discretion in denying his
    motion under Rule 56(d) to defer summary judgment for additional discovery.
    -13-
    Reviewing for abuse of discretion, we disagree. See Toben v. Bridgestone Retail
    Operations, LLC, 
    751 F.3d 888
    , 895 (8th Cir. 2014) (quoting Stringfellow v. Perry,
    
    869 F.2d 1140
    , 1143 (8th Cir. 1989)) ("District courts are afforded wide discretion
    in their handling of discovery matters.").
    The district court was well within its wide discretion to deny Dr. Elkharwily's
    motion to defer the summary judgment ruling. By Rule 56(d), a court may defer
    considering a motion for summary judgment or allow time for discovery "[i]f a
    nonmovant shows by affidavit or declaration that, for specified reasons, it cannot
    present facts essential to justify its opposition." Fed. R. Civ. P. 56(d). Dr. Elkharwily
    moved to defer the summary judgment ruling in order to conduct more discovery.
    However, not only did Dr. Elkharwily engage in exhaustive discovery through two
    years of litigation but the district court had already granted him three additional
    depositions on top of the ten under the scheduling order. Dr. Elkharwily had no
    meritorious justification for additional discovery. The district court did not abuse its
    discretion.
    III
    The judgment is affirmed.4
    ______________________________
    4
    We have examined the other issues raised by Dr. Elkharwily and find none
    merits discussion. We affirm those issues without comment. See 8th Cir. R. 47B.
    -14-